Correlation Engine 2.0
Clear Search sequence regions


  • adult (2)
  • bone (2)
  • case report (1)
  • CYP19A1 (4)
  • diagnosis (1)
  • epiphysis (1)
  • estradiol (1)
  • estrogen (1)
  • female (2)
  • fetus (1)
  • gynecomastia (1)
  • humans (1)
  • mothers (1)
  • patients (5)
  • pregnancy (2)
  • prognosis (1)
  • protein human (1)
  • sex (1)
  • Sizes of these terms reflect their relevance to your search.

    Aromatase deficiency (AD) is a rare autosomal recessive genetic disease caused by loss-of-function mutations in aromatase gene (CYP19A1), leading to congenital estrogen deficiency syndrome. Both mothers of AD patients during pregnancy and female AD fetus show virilization, while male patients are usually diagnosed in adulthood due to continued height increase and metabolic abnormalities. In 2019, a patient with AD was admitted in the Second Xiangya Hospital. The patient was a 37-year-old adult male who continued to grow linearly after adulthood. His estradiol was below the measurable line, the follicle-stimulating hormone (FSH) increased, bone age delayed, epiphysis unfused, and the bone mass reduced. CYP19A1 gene detection showed that c.1093C>T, p.R365W was homozygous mutation. This disease is rare in clinic. Clinicians need to raise awareness of the disease for early diagnosis and treatment to improve the long-term prognosis of patients.

    Citation

    Hongli Li, Songbo Fu, Ruchun Dai, Zhifeng Sheng, Wei Liu. Aromatase deficiency caused by mutation of CYP19A1 gene: A case report. Zhong nan da xue xue bao. Yi xue ban = Journal of Central South University. Medical sciences. 2022 Jun 28;47(6):794-800

    Expand section icon Mesh Tags

    Expand section icon Substances


    PMID: 35837780

    View Full Text